AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 44 min read$AMWL

American Well Corp (AMWL): Results of Operations and Financial Condition

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026 BOSTON, August 4 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026

Original reporting
SEC EDGAR 8-K
Published Aug 4, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 3:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$AMWL
Bullish
medium confidence
Mentioned
$AMWL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AMWLBullishMed
01

Why it matters

Traders can reprice the stock based on the updated revenue and adjusted EBITDA guidance ranges, plus the stated objective of positive operating cash flow in Q4 2026.

02

Market read

The filing provides fresh, numeric guidance updates (2026 and Q3) and Q2 operating metrics (revenue, gross margin, EBITDA trend) that can drive near-term positioning.

03

What to watch

The filing emphasizes DHA contractor intent and cash-flow timing for Q4, but it also flags risks around client transitions, telehealth demand volatility, and cybersecurity/privacy compliance.

Relevance 7/10Novelty 8/10Timing: after-hours filing on Aug 4, 2026, with Q3 and 2026 guidance ranges

Background

This is an SEC 8-K with Exhibit 99.1 reporting Amwell’s Q2 2026 results and updated financial outlook, including Q3 2026 ranges.

Company-level read

Ticker impact

$AMWLBullishMedium confidence
Context

Amwell reported Q2 2026 revenue of $52.0M, gross margin of 53%, and raised the low end of 2026 revenue and adjusted EBITDA guidance.

Expected impact

Near-term bias upward on guidance credibility, with volatility risk given continued GAAP net losses and non-GAAP framing.

Evidence & confidence

The filing includes specific Q2 results and updated 2026 and Q3 ranges, which are actionable for positioning. However, the company does not reconcile forward-looking adjusted EBITDA to GAAP, and GAAP net loss persists, limiting conviction.

Market effects

Sector

Reinforces a potential inflection narrative for telehealth/SaaS healthcare platforms via subscription growth and improving EBITDA trajectory.

Regional

No specific regional spillover disclosed beyond US healthcare contracting.

Global

Limited, as the disclosed guidance and DHA relationship are US-focused.

Counterpoint

What could challenge this read

Non-GAAP adjusted EBITDA remains negative and GAAP net loss is still sizable, so the guidance raise may not translate into durable profitability.

Key entities

  • issuer
    American Well Corp

    NYSE-listed SaaS-based healthcare platform provider reporting Q2 2026 results and updated guidance.

  • customer
    Defense Health Agency (DHA)

    Referenced as intending to make Amwell a prime contractor, supporting the platform endorsement narrative.

Read at source← All news

Related articles

AUG 12
$AMWLMedAI 8/10

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.

fool.com6 min
SEP 17
$TSLAHighAI 9/10

Tesla Posted Negative $1.1 Billion in Free Cash Flow Last Quarter as Elon Musk Ramps Up Spending on Robotaxis and Optimus. Here's Why the Company's $43.5 Billion Cash Cushion Still Matters.

Tesla reported a 26% revenue increase to $22.5B in Q2, with net income of $1.11B, but negative free cash flow of $1.1B due to $5.79B in capital expenditures. The company's $43.5B cash position provides a buffer for growth investments in robotaxis, Optimus robots, and semiconductors. Tesla's market share in U.S. EVs has risen despite industry contraction, but competition from Chinese rivals like BYD persists.

fool.com2 min
SEP 17
$BWINMed

Michael Dell Just Made a $7.7 Billion Bet on This Insurance Stock

Michael Dell is acquiring Baldwin & Co. (BWIN) for $7.7B. Baldwin reported Q2 revenue of $492.9M (+30% YoY), adjusted net income of $68.5M, and adjusted EBITDA of $116.7M (+37%). Management guided Q3 revenue to $485M-$495M and full-year revenue to $2.01B-$2.05B. Analysts have mixed targets, with a consensus 'Moderate Buy' and average target of $33.

yahoo.com2 min
SEP 17
$AMZNMedAI 8/10

Should You Buy Amazon Stock For The Demand AWS Cannot Yet Serve?

Amazon.com (AMZN) stock is down 13% from its 52-week high, despite AWS's 36.7% YOY revenue growth in Q2 2026. AWS's backlog of committed contracts reached $496 billion, with demand outpacing capacity. AWS's operating margin improved 520 basis points YOY, excluding energy contract gains. Management attributes growth to AI workloads and efficient capacity use.

yahoo.com3 min